BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11357650)

  • 1. Genetic analysis and gene expression with mini-Epstein-Barr virus plasmids.
    Kilger E; Hammerschmidt W
    Methods Mol Biol; 2001; 174():23-35. PubMed ID: 11357650
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction of plasmid vectors into cells via electroporation.
    Kirchmaier AL
    Methods Mol Biol; 2001; 174():137-45. PubMed ID: 11357637
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the expression and function of the EBV-encoded small RNAs, the EBERs, in heterologous cells.
    Laing KG; Matys V; Clemens MJ
    Methods Mol Biol; 2001; 174():45-66. PubMed ID: 11357670
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.
    Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST
    J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
    Niller HH; Wolf H; Minarovits J
    Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epstein-barr virus gene expression in latent infection and B-lymphocyte growth transformation].
    Harada S
    Uirusu; 2002 Jun; 52(1):129-34. PubMed ID: 12227161
    [No Abstract]   [Full Text] [Related]  

  • 9. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
    Yamashita Y; Tsurumi T; Mori N; Kiyono T
    Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell transformation induced by Epstein-Barr virus--living dangerously.
    Rowe M
    Semin Cancer Biol; 2001 Dec; 11(6):403-5. PubMed ID: 11669601
    [No Abstract]   [Full Text] [Related]  

  • 11. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.
    Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR
    Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of lymphoblastoid cell lines (LCLs).
    Frisan T; Levitsky V; Masucci M
    Methods Mol Biol; 2001; 174():125-7. PubMed ID: 11357634
    [No Abstract]   [Full Text] [Related]  

  • 15. IFN-alpha-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas.
    Pegtel DM; Subramanian A; Meritt D; Tsai CH; Sheen TS; Golub TR; Thorley-Lawson DA
    Cancer Res; 2007 Jan; 67(2):474-81. PubMed ID: 17234754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
    Swaminathan S
    Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Latency vs lytic cycle of Epstein-Barr virus: regulation of a viral gene expression is the clue].
    Gruffat H; Manet E; Sergeant A
    Pathol Biol (Paris); 2004 Mar; 52(2):63-5. PubMed ID: 15001233
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation.
    Jeon JP; Kim JW; Park B; Nam HY; Shim SM; Lee MH; Han BG
    Acta Virol; 2008; 52(3):151-9. PubMed ID: 18999889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biological aspects of carcinogenesis associated with the Epstein-Barr virus].
    Afanas'eva TA; Gurtsevich VE
    Mol Biol (Mosk); 1998; 32(6):940-7. PubMed ID: 9929868
    [No Abstract]   [Full Text] [Related]  

  • 20. [MTHFR gene expression in EB virus transformed human B lymphoblasts].
    Zhu H; Zhao R; Li Y; Li Z
    Wei Sheng Yan Jiu; 2000 Jul; 29(4):196-8. PubMed ID: 12520914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.